GSK-3 Inhibitor IX (CAS: 667463-62-9)
|
SKU-Pack Size | Availability | Size | Price | |
EBC51068-1ML | In Stock | 1mL(10mM in DMSO) | €128.70 | |
EBC51068-2MG | In Stock | 2mg | €63.70 | |
EBC51068-5MG | In Stock | 5mg | €102.70 | |
EBC51038-10MG | In Stock | 10mg | €141.70 | |
EBC51037-50MG | In Stock | 50mg | €518.70 |
Please Select The Country You Are In To Find Your Local Distributor. |
OlaSciences | Phone£º+33 (0) 9 77 4001 556 | |
87, rue des Suisses 65000 Nanterre, | E-mail£ºola@olasciences.com | |
France | France | Web£ºwww.olasciences.com |
Product Information | |||||||||||||||||||||
Synonym(s) | BIO, 6-Bromoindirubin-3'-oxime | ||||||||||||||||||||
Chemical Name | (2'Z,3'E)-6-Bromoindirubin-3'-oxime | ||||||||||||||||||||
Application | GSK-3 Inhibitor IX is a specific inhibitor of GSK-3 | ||||||||||||||||||||
CAS Number | 667463-62-9 | ||||||||||||||||||||
Purity | ¡Ý99.0% | ||||||||||||||||||||
Molecular Weight | 356.17 | ||||||||||||||||||||
Molecular Formula | C₁₆H₁₀BrN₃O₂ | ||||||||||||||||||||
SMILES | O/N=C1/C(=C2C(=O)Nc3cc(Br)ccc/23)Nc2ccccc12 | ||||||||||||||||||||
Target & IC50 | GSK-3¦Á/¦Â: IC50 = 5 nM Cdk5/p25: IC50 = 83 nM Cdk2/A: IC50 = 300 nM Cdk1/B: IC50 = 320 nM Cdk4/D1: IC50 = 10 ¦ÌM |
||||||||||||||||||||
Solubility | DMSO: 71 mg/mL (199.34 mM) Ethanol: 21 mg/mL (58.96 mM) |
||||||||||||||||||||
Preparing Stock Solutions |
|
||||||||||||||||||||
Shipping | Gel Pack | ||||||||||||||||||||
Storage | Store at -20¡ãC | ||||||||||||||||||||
Research Use | For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. |
Product Description | |
GSK-3 Inhibitor IX is a cell-permeable selective irreversible inhibitor of glycogen synthase kinase-3 (GSK-3). This inhibitory effect is reported to activate the Wnt signaling pathway and promote self-renewal in human and mouse cells. BIO is also useful in the differentiation of cardiomyocytes from human embryonic cells and Induced pluripotent stem cells as well as cellular reprogramming of mouse cell lines into iPS cells. |
Specific Protocols | |